Forte Biosciences, Inc.
FBRX
$11.16
-$0.10-0.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 106.14M | 45.86M | 58.37M | 16.36M | 24.50M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 884.00K | 853.00K | 2.65M | 1.03M | 900.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 588.00K | 449.00K | 336.00K | 274.00K | 313.00K |
| Total Current Assets | 107.62M | 47.16M | 61.35M | 17.67M | 25.71M |
|
|
|||||
| Total Current Assets | 107.62M | 47.16M | 61.35M | 17.67M | 25.71M |
| Net Property, Plant & Equipment | 110.00K | 125.00K | 77.00K | 86.00K | 96.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 57.00K | 176.00K | 138.00K | 192.00K | 271.00K |
| Total Assets | 107.78M | 47.46M | 61.56M | 17.95M | 26.08M |
|
|
|||||
| Total Accounts Payable | 5.30M | 5.02M | 4.88M | 5.16M | 5.28M |
| Total Accrued Expenses | 3.87M | 4.01M | 4.20M | 3.42M | 3.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.17M | 9.03M | 9.08M | 8.58M | 9.12M |
|
|
|||||
| Total Current Liabilities | 9.17M | 9.03M | 9.08M | 8.58M | 9.12M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.17M | 9.03M | 9.08M | 8.58M | 9.12M |
|
|
|||||
| Common Stock & APIC | 279.52M | 208.08M | 206.47M | 156.21M | 155.42M |
| Retained Earnings | -180.90M | -169.65M | -154.00M | -146.84M | -138.45M |
| Treasury Stock & Other | -- | -- | 11.00K | 1.00K | -7.00K |
| Total Common Equity | 98.61M | 38.43M | 52.48M | 9.37M | 16.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 98.61M | 38.43M | 52.48M | 9.37M | 16.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 98.61M | 38.43M | 52.48M | 9.37M | 16.96M |
|
|
|||||